Thank you for your reply ex. With the company using both facilities to manufacture DCAX (Advent and CRL) and with their plans to have them overlap each other to create redundancy, I can imagine that both facilities would be scrutinized by each RA involved. Overall though, the general submission to each agency should be similar save plans to procure and deliver DCVAX by the contract manufacturers.
Market Data 
Markets 
